Distribution of Matrix Metalloproteinases in Human Atherosclerotic Carotid Plaques and Their Production by Smooth Muscle Cells and Macrophage Subsets

Molecular Imaging and Biology

Volumn 18, Issue 2, 2016, Pages 283-291

  Jager, Nynke A ^a   Wallis de Vries, Bastiaan M ^a   Hillebrands, Jan Luuk ^a   Harlaar, Niels J ^a   Tio, René A ^a   Slart, Riemer H J A ^a   van Dam, Gooitzen M ^a   Boersma, Hendrikus H ^a   Zeebregts, Clark J ^a   Westra, Johanna ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Atherosclerotic plaque; Macrophage; Matrix metalloproteinase; MMPSense; Smooth muscle cell

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD163 ANTIGEN; CD68 ANTIGEN; COLLAGENASE 3; GELATINASE A; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 4; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 16; MESSENGER RNA; NEUTROPHIL COLLAGENASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ARTICLE; CAROTID ATHEROSCLEROSIS; CELL SUBPOPULATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ANALYSIS; ENZYME LOCALIZATION; ENZYME RELEASE; ENZYME SYNTHESIS; EX VIVO STUDY; FEMALE; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MACROPHAGE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; UPREGULATION; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY OBSTRUCTION; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; FLUORESCENCE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; RISK FACTOR; SMOOTH MUSCLE CELL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CAROTID STENOSIS; DEMOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MYOCYTES, SMOOTH MUSCLE; PLAQUE, ATHEROSCLEROTIC; RISK FACTORS; RNA, MESSENGER;

EID: 84959888740     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-015-0882-0     Document Type: Article

References (33)

1. Libby P (2012) Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 32:2045–2051
2. Shah PK (2009) Inflammation and plaque vulnerability. Cardiovasc Drugs Ther 23:31–40
3. Ross R (1999) Atherosclerosis--an inflammatory disease. N Engl J Med 340:115–126
4. Newby AC, George SJ, Ismail Y et al (2009) Vulnerable atherosclerotic plaque metalloproteinases and foam cell phenotypes. Thromb Haemost 101:1006–1011
5. Newby AC (2005) Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 85:1–31
6. Medbury HJ, James V, Ngo J et al (2013) Differing association of macrophage subsets with atherosclerotic plaque stability. Int Angiol 32:74–84
7. Jager NA, Teteloshvili N, Zeebregts CJ et al (2012) Macrophage folate receptor-beta (FR-beta) expression in auto-immune inflammatory rheumatic diseases: a forthcoming marker for cardiovascular risk? Autoimmun Rev 11:621–626
8. Mantovani A, Sica A, Sozzani S et al (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25:677–686
9. Wolfs IM, Donners MM, de Winther MP (2011) Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarisation. Thromb Haemost 106:763–771
10. Raffetto JD, Khalil RA (2008) Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 75:346–359
11. Loftus IM, Naylor AR, Goodall S et al (2000) Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption. Stroke 31:40–47
12. Alvarez B, Ruiz C, Chacon P et al (2004) Serum values of metalloproteinase-2 and metalloproteinase-9 as related to unstable plaque and inflammatory cells in patients with greater than 70% carotid artery stenosis. J Vasc Surg 40:469–475
13. Taurino M, Raffa S, Mastroddi M et al (2007) Metalloproteinase expression in carotid plaque and its correlation with plasma levels before and after carotid endarterectomy. Vasc Endovascular Surg 41:516–521
14. Sapienza P, di Marzo L, Borrelli V et al (2004) Basic fibroblast growth factor mediates carotid plaque instability through metalloproteinase-2 and −9 expression. Eur J Vasc Endovasc Surg 28:89–97
15. Kunte H, Amberger N, Busch MA et al (2008) Markers of instability in high-risk carotid plaques are reduced by statins. J Vasc Surg 47:513–522
16. Eldrup N, Gronholdt ML, Sillesen H, Nordestgaard BG (2006) Elevated matrix metalloproteinase-9 associated with stroke or cardiovascular death in patients with carotid stenosis. Circulation 114:1847–1854
17. Turu MM, Krupinski J, Catena E et al (2006) Intraplaque MMP-8 levels are increased in asymptomatic patients with carotid plaque progression on ultrasound. Atherosclerosis 187:161–169
18. Johnson JL, George SJ, Newby AC, Jackson CL (2005) Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries. Proc Natl Acad Sci U S A 102:15575–15580
19. Wallis de Vries BM, van Dam GM et al (2008) Current imaging modalities to visualize vulnerability within the atherosclerotic carotid plaque. J Vasc Surg 48:1620–1629
20. Sanz J, Fayad ZA (2008) Imaging of atherosclerotic cardiovascular disease. Nature 451:953–957
21. Deguchi JO, Aikawa M, Tung CH et al (2006) Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo. Circulation 114:55–62
22. Jaffer FA, Kim DE, Quinti L et al (2007) Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor. Circulation 115:2292–2298
23. Wallis de Vries BM, Hillebrands JL, van Dam GM et al (2009) Images in cardiovascular medicine. Multispectral near-infrared fluorescence molecular imaging of matrix metalloproteinases in a human carotid plaque using a matrix-degrading metalloproteinase-sensitive activatable fluorescent probe. Circulation 119:e534–e536
24. Meerwaldt R, Hermus L, Reijnen MM, Zeebregts CJ (2010) Carotid endarterectomy: current consensus and controversies. Surg Technol Int 20:283–291
25. Jager NA, Westra J, van Dam GM et al (2012) Targeted folate receptor beta fluorescence imaging as a measure of inflammation to estimate vulnerability within human atherosclerotic carotid plaque. J Nucl Med 53:1222–1229
26. Jager NA, Westra J, Golestani R et al (2014) Folate receptor-beta imaging using 99mTc-folate to explore distribution of polarized macrophage populations in human atherosclerotic plaque. J Nucl Med 55:1945–1951
27. Jaffer FA, Vinegoni C, John MC et al (2008) Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis. Circulation 118:1802–1809
28. Choudhary S, Higgins CL, Chen IY et al (2006) Quantitation and localization of matrix metalloproteinases and their inhibitors in human carotid endarterectomy tissues. Arterioscler Thromb Vasc Biol 26:2351–2358
29. Sluijter JP, Pulskens WP, Schoneveld AH et al (2006) Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions: a study in human endarterectomy specimen pointing to a role for different extracellular matrix metalloproteinase inducer glycosylation forms. Stroke 37:235–239
30. Verhoeven B, Hellings WE, Moll FL et al (2005) Carotid atherosclerotic plaques in patients with transient ischemic attacks and stroke have unstable characteristics compared with plaques in asymptomatic and amaurosis fugax patients. J Vasc Surg 42:1075–1081
31. Heo SH, Cho CH, Kim HO et al (2011) Plaque rupture is a determinant of vascular events in carotid artery atherosclerotic disease: involvement of matrix metalloproteinases 2 and 9. J Clin Neurol 7:69–76
32. Tziakas DN, Lazarides MK, Tentes IK et al (2005) Gelatinases [matrix metalloproteinase-2 (MMP-2) and MMP-9] induce carotid plaque instability but their systemic levels are not predictive of local events. Ann Vasc Surg 19:529–533
33. Zajac E, Schweighofer B, Kupriyanova TA et al (2013) Angiogenic capacity of M1- and M2-polarized macrophages is determined by the levels of TIMP-1 complexed with their secreted proMMP-9. Blood 122:4054–4067